Retatrutide—A Game Changer in Obesity Pharmacotherapy

This review synthesizes findings on retatrutide, a novel triple receptor agonist, highlighting its mechanisms, efficacy, safety profile and potential as a groundbreaking advancement in obesity and T2DM pharmacotherapy.

Educational Objectives

Educational Aim:

To provide a comprehensive review of retatrutide, examining its unique triple-agonist mechanism, efficacy in weight management and glycemic control, and its potential role in the future of obesity pharmacotherapy.

Educational Outcomes:
Upon completion of this module practitioners should have a clear understanding of:

1. The mechanism of action of retatrutide as a triple receptor agonist targeting GLP-1, GIP, and glucagon.
2. The efficacy of retatrutide in promoting significant weight loss and improving metabolic parameters as demonstrated in preclinical and clinical trials.
3. The safety profile, common adverse events, and current limitations regarding the use of retatrutide in specific populations (e.g., pediatrics).

Instructions for this Module

• Read the supplied reading material and complete the quiz that follows;
• You have three attempts to pass the quiz;
• The pass grade is 70%;
• You need to pass the quiz to claim your CPD certificate;
• Please click on the CPD certificate link below to claim your CPD certificate and to update your CPD Manager.

If you need any assistance to complete this module, please Contact us